Primary pineal melanoma with leptomeningeal spreading: Case report and review of the literature

Clinical Neuropathology

Volumn 28, Issue 5, 2009, Pages 387-394

  Martin Blondel, G ^a   Rousseau, A ^a   Boch, A L ^a   Cacoub, P ^a   Sène, Damien ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Central nervous system; Leptomeninges; Melan A; Melanoma; Pineal gland

Indexed keywords

GADOLINIUM; MELAN A; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; TEMOZOLOMIDE; MART1 ANTIGEN; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; ANAMNESIS; ARTICLE; BRAIN BIOPSY; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOCYTE; MELANOMA; MENINGEAL METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PINEAL BODY TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; SEIZURE; BRAIN; DIFFERENTIAL DIAGNOSIS; FATALITY; MALE; MENINGIOMA; METABOLISM; METASTASIS; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; REVIEW; SCINTISCANNING;

ADULT; ANTIGENS, NEOPLASM; BRAIN; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MENINGEAL NEOPLASMS; NEOPLASM PROTEINS; PINEALOMA; PROGNOSIS; S100 PROTEINS;

EID: 70350057059     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.2379/NP300160     Document Type: Article

References (20)

1. Arlant PA, Grunnet ML et al. Primary malignant melanoma of the pineal region. Surg Neurol. 1977; 7: 121-123.
2. Barron J, Morris-Larkin C, et al. Long survival of primary pineal melanoma with radiation treatment only. Can J Neurol Sci. 2007; 34: 251-253.
3. Bookland M, Anderson WS et al. Primary pineal malignant melanoma. Pediatr Neurosurg. 2007; 43: 303-308.
4. Brat DJ, Giannini C, et al. Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol. 1999; 23: 745-754.
5. de Wit NJ, van Muijen GN et al. Immunohistochemistry in melanocytic proliferative lesions. Histopathology. 2004; 44: 517-541.
6. Facey K, Bradbury I et al. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007; 11: 3-4, 11-267.
7. Fathallah-Shaykh HM, Zimmerman C et al. Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. Acase report. Cancer. 1996; 77: 1544-1550.
8. Greco Crasto S, Soffietti R et al. Primitive cerebral melanoma: case report and review of the literature. Surg Neurol. 2001; 55: 163-168.
9. Hirato J, Nakazato Y. Pathology of pineal region tumors. J Neurooncol. 2001; 54: 239-249.
10. Mitchell PJ, Funt SA, et al. Primary pineal and meningeal malignant melanomatosis. J Clin Neurosci. 1998; 5: 353-356.
11. Offiah CJ, Laitt RD. Case report: Intracranial meningeal melanocytoma: a cause of high signal on T1- and low signal on T2-weighted MRI. Clin Radiol. 2006; 61: 294-298.
12. Ohsie SJ, Sarantopoulos GPet al. Immunohistochemical characteristics of melanoma.J Cutan Pathol. 2008; 35: 433-444.
13. Plowman PN, Saunders CA et al. On the usefulness of brain PET scanning to the pediatric neuro-oncologist. Br J Neurosurg. 1997; 11: 525-532.
14. Rousseau A, Bernier M et al. Primary intracranial melanocytic tumor simulating pituitary macroadenoma: case report and review of the literature. Neurosurgery. 2005; 57: E369.
15. Rubino GJ, King WA et al. Primary pineal melanoma: case report. Neurosurgery. 1993; 33: 511-515.
16. Snyder ML, Paulino AF. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas. Head Neck. 2002; 24: 52-55.
17. Suzuki T, Yasumoto Y et al. Primary pineal melanocytic tumor. Case report. J Neurosurg. 2001; 94: 523-527.
18. Tosaka M, Tamura M et al. Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanoma. Case report. J Neurosurg. 2001; 94: 528-532.
19. Weber RW, O'Day S et al. Low-dose outpatient chemo biotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma. J Clin Oncol. 2005; 23: 8992-9000.
20. Yamane K, Shima T et al. Primary pineal melanoma with long-term survival: case report. Surg Neurol. 1994; 42: 433-437.